A new study suggests GLP-1 receptor agonists like Ozempic and Wegovy may significantly improve colon cancer survival rates.

Scientists have known that obesity and metabolic dysfunction can make cancers more aggressive. Tumors thrive in bodies ...

How Ozempic Is Changing Thanksgiving According to the independent research and polling source KFF, one in eight Americans reported taking a GLP-1 receptor agonist ...

GLP-1 receptors - the drugs behind Ozempic and Mounjaro - could have great benefits for colon cancer patients, the study ...

The biotech firm’s shareholder approval opens the door for the US drugmaker to enter the booming weight loss drug market.

Novo Nordisk maintains strong growth prospects, driven by obesity treatment market expansion. See why NVO stock is a strong ...

This week, the White House announced a deal with Eli Lilly and Novo Nordisk to lower the cost of their GLP-1 weight loss ...

The comedian shared snaps of herself rocking a red strapless mini dress and a pair of black slingback heels via Instagram.

Denmark’s corporate foundations grew out of a late 19th-century tradition of setting up entities to both own a company and ...

Medications like Wegovy and Ozempic, known for managing diabetes and promoting weight loss, may also be linked to ...

Amy Schumer is starting fresh amid her recent weight loss. “Back on my staircase bulls*** again,” the comedian, 44, captioned ...